US2010228007A1PendingUtilityA1
Mhc-peptide complex binding ligands
Assignee: TECHNION RES & DEV FOUNDATIONPriority: Feb 20, 2002Filed: Mar 16, 2010Published: Sep 9, 2010
Est. expiryFeb 20, 2022(expired)· nominal 20-yr term from priority
C07K 16/2896C07K 2317/34C07K 16/40A61P 35/00C07K 2317/55A61K 2039/505C07K 16/2833A61P 37/04C07K 2317/21
52
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
Disclosed are protein ligands comprising an immunoglobulin heavy chain variable (VH) domain and an immunoglobulin light chain variable (VL) domain, wherein the proteins bind a complex comprising an MHC and a peptide, do not substantially bind the MHC in the absence of the bound peptide, and do not substantially bind the peptide in the absence of the MHC, and the peptide is a peptide fragment of gp100, MUC1, TAX, or hTERT. Also disclosed are methods of using and identifying such ligands.
Claims
exact text as granted — not AI-modified1 - 3 . (canceled)
4 . A protein comprising an immunoglobulin heavy chain variable (VH) domain and an immunoglobulin light chain variable (VL) domain, wherein the protein binds a complex comprising an MHC and a peptide, does not substantially bind said MHC in an absence of said peptide, and does not substantially bind said peptide in an absence of said MHC, wherein said peptide is a peptide fragment of gp100, MUC1 or TAX.
5 . The protein of claim 4 , wherein said MHC is MHC class I.
6 . The protein of claim 5 , wherein said MHC class I comprises HLA-A*0201.
7 . The protein of claim 4 , wherein said peptide fragment of said gp100 is G9-209 (SEQ ID NO:1).
8 . The protein of claim 4 , wherein said peptide fragment of said gp100 is G9-280 (SEQ ID NO:2).
9 . The protein of claim 4 , wherein said peptide fragment of said gp100 is G9-154 (SEQ ID NO:3).
10 . The protein of claim 4 , wherein said peptide fragment of said MUC1 is D6 (SEQ ID NO:4).
11 . The protein of claim 4 , wherein said peptide fragment of said TAX is set forth by SEQ ID NO:121.
12 . The protein of claim 7 , wherein said protein comprises all six CDRs of 1A11 (SEQ ID NOs:8 and 10), 1A7 (SEQ ID NOs:12 and 14), 1A9 (SEQ ID NOs:16 and 18), 1C8 (SEQ ID NOs:20 and 22), 1D7 (SEQ ID NOs:24 and 26) or 1G2 (SEQ ID NOs:28 and 30).
13 . The protein of claim 8 , wherein said protein comprises all six CDRs of 2B2 (SEQ ID NOs:32 and 34), 2C5 (SEQ ID NOs:36 and 38), 2D1 (SEQ ID NOs:40 and 42) or 2F1 (SEQ ID NOs:44 and 46).
14 . The protein of claim 9 , wherein said protein comprises all six CDRs of G2D12 (SEQ ID NOs:48 and 50), G3F12 (SEQ ID NOs:52 and 54), G3F3 (SEQ ID NOs:56 and 58) or G3G4 (SEQ ID NOs:60 and 62).
15 . The protein of claim 10 , wherein said protein comprises all six CDRs of M3A1 (SEQ ID NOs:64 and 66) or M3B8 (SEQ ID NOs:68 and 70).
16 . The protein of claim 10 , wherein said protein comprises all six CDRs of T3E3 (SEQ ID NOs:72 and 74), T3F1 (SEQ ID NOs:76 and 78) or T3F2 (SEQ ID NOs:80 and 82).Cited by (0)
No later patents cite this yet.
References (0)
No backward citations on record.